Page last updated: 2024-10-26

disulfiram and Carcinoma, Ductal, Pancreatic

disulfiram has been researched along with Carcinoma, Ductal, Pancreatic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, Z1
Xie, X1
Tan, G1
Xie, F1
Liu, N1
Li, W1
Sun, X1
Cong, J1
Wang, Y1
Zhang, X1
Zhang, N1
Liu, L1
Soukup, K1
Michelakos, T1
Hong, T1
DeLeo, A1
Cai, L1
Sabbatino, F1
Ferrone, S1
Lee, H1
Levina, V1
Fuchs, B1
Tanabe, K1
Lillemoe, K1
Ferrone, C1
Wang, X1
Kim, SK1
Kim, H2
Lee, DH1
Kim, TS1
Kim, T1
Chung, C1
Koh, GY1
Lim, DS1

Other Studies

3 other studies available for disulfiram and Carcinoma, Ductal, Pancreatic

ArticleYear
Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tu

2021
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram.
    Cancer letters, 2017, 11-28, Volume: 409

    Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carc

2017
Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Aldehyde Dehydrogenase; Analysis of Variance; Animals; Blotting, Western; Carcinoma, Pancreatic Duct

2013